News

Exelixis, Inc. announced that it has entered into an exclusive collaboration, option and license agreement with Aurigene Discovery Technologies Limited (Aurigene), the India-based…
Read More...

Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC ("Cipla Gulf"), a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited announced that Alvotech and…
Read More...

Nephron Pharmaceuticals Corporation and Rapid Micro Biosystems announced the Nephron 503(b) Outsourcing division will deliver critical medical supplies to hospitals faster than ever,…
Read More...

Eli Lilly and Company announced that Verzenio (abemaciclib) demonstrated a statistically significant improvement in overall survival in the Phase 3 MONARCH 2 clinical trial. These…
Read More...

Pfizer Inc. announced the successful completion of its acquisition of Array BioPharma Inc., advancing breakthrough science for the discovery, development and commercialization of…
Read More...

Lyndra Therapeutics, the company making daily pills a thing of the past, announced it has received a $13 million grant from the Bill & Melinda Gates Foundation for the development…
Read More...

Sunovion Pharmaceuticals Inc. (Sunovion) announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for dasotraline, a novel dopamine and…
Read More...

NEC Corporation announced the acquisition of OncoImmunity AS, a Norway-based bioinformatics company that develops proprietary machine learning software to support the fight against…
Read More...

Merck, a leading science and technology company, announced the signing of a non-binding Memorandum of Understanding (MoU) with Phanes Therapeutics, Inc. (Phanes) for a collaboration on…
Read More...

Lonza announced the start of expansion to its bioconjugation facility in Visp, Switzerland together with the successful commercial approval of a third antibody-drug-conjugate (ADC)…
Read More...

Zambon, a multinational pharmaceutical company that focuses on innovation and development with the aim to improve the quality of people’s health and patients’ lives, announces the…
Read More...

Epizyme, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the company’s New Drug Application (NDA) for accelerated approval of tazemetostat, its…
Read More...

Aucta Pharmaceuticals, Inc. (Aucta), a technology based company focusing on the development and commercialization of Branded Specialty Products, announced that the Company has entered…
Read More...

BioCardia, Inc. announced it has signed an extension to a 2017 development agreement with AstraZeneca for BioCardia’s Helix biotherapeutic delivery catheter system. Under the terms…
Read More...

Valneva SE, a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs, and the Coalition for Epidemic Preparedness Innovations (CEPI)…
Read More...

Gemphire Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of dyslipidemia as well as nonalcoholic fatty liver disease, and…
Read More...

Opiant Pharmaceuticals, Inc. announced that it has signed an agreement with Sanofi to manufacture Opiant’s investigational agent OPNTOO4 (drinabant) for the treatment of Acute…
Read More...

REGENXBIO Inc. announced an expansion of its pipeline to include novel treatments for hereditary angioedema (HAE) and neurodegenerative diseases, including tauopathies, using NAV…
Read More...

Uman Diagnostics, now part of Quanterix, and Bio-Techne announced a strategic License and Supply Agreement for the antibodies used in the quantification of neurofilament light (Nf-L) on…
Read More...

Ligand Pharmaceuticals Incorporated announces the signing of an agreement with Ab Initio Biotherapeutics whereby Ligand will acquire Ab Initio for $12 million in cash. Ab Initio was a…
Read More...